Quarterly report pursuant to Section 13 or 15(d)

Subsequent Event (Details Textual)

v2.4.0.6
Subsequent Event (Details Textual) (USD $)
9 Months Ended
Sep. 30, 2012
Sep. 30, 2012
Subsequent Event [Member]
Oct. 05, 2012
Subsequent Event [Member]
Royalty Contract [Member]
Oct. 05, 2012
PDL BioPharma Inc [Member]
Subsequent Event [Member]
Royalty Contract [Member]
Aug. 14, 2012
PDL BioPharma Inc [Member]
Subsequent Event [Member]
Royalty Contract [Member]
Subsequent Event (Textual) [Abstract]          
Royalty contract period   8 years      
Consideration for royalty sold     $ 20,800,000 $ 19,050,000 $ 1,750,000
Expiry date for exercise of put option Nov. 04, 2016        
Outstanding balance prepayment penalty. $ 370,000